Reporting cutaneous melanoma to cancer registries in the United States

Journal of the American Academy of Dermatology

Volumn 49, Issue 4, 2003, Pages 624-630

  Hall, H Irene ^a,c   Jamison, Patricia ^a   Fulton, John P ^d   Clutter, Gayle ^a   Roffers, Steven ^b   Parrish, Pam ^d  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b EMORY UNIVERSITY   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SKIN CANCER; UNITED STATES;

EID: 0141533265     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0190-9622(03)00885-5     Document Type: Article

References (25)

1. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller PA, Clegg L, et al, editors. SEER Cancer Statistics Review, 1973-1998. Bethesda (MD): National Cancer Institute, 2001. Accessed October, 2001. Available from: URL: http://seer.cancer.gov/Publications/CSR1973_1998/.
2. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001;93:678-83.
3. Hall HI, Miller DR, Rogers JD, Bewerse B. Update on the incidence and mortality from melanoma in the United States. J Am Acad Dermatol 1999;40:35-42.
4. Dennis LK, White E, Lee JA. Recent cohort trends in malignant melanoma by anatomic site in the United States. Cancer Causes Control 1993;4:93-100.
5. Karagas MR, Thomas DB, Roth GJ, Johnson LK, Weiss NS. The effects of changes in health care delivery on the reported incidence of cutaneous melanoma in western Washington State. Am J Epidemiol 1991;133:58-62.
6. Seiffert J. Underreporting of melanoma. J Natl Cancer Inst 1992;84:289.
7. Melia J, Frost T, Graham-Brown R, Hunter J, Marsden A, du Vivier A, et al. Problems with registration of cutaneous malignant melanoma in England. Br J Cancer 1995;72:224-8.
8. Young JL, Roffers SD, Ries LA, Fritz AG, Hurlbut AA. SEER Summary staging manual-2000: codes and coding instructions. Bethesda (MD): National Cancer Institute, 2001. NIH Publication No. 01-4969.
9. Koh HK, Clapp RW, Barnett JM, Nannery WM, Tahan SR, Geller AC, et al. Systematic underreporting of cutaneous malignant melanoma in Massachusetts. J Am Acad Dermatol 1991;24:545-50.
10. Zippin C, Lum D, Hankey BF. Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 1995;76:2343-50.
11. Merlino LA, Sullivan KJ, Whitaker DC, Lynch CF. The independent pathology laboratory as a reporting source for cutaneous melanoma incidence in Iowa, 1977-1994. J Am Acad Dermatol 1997;37:578-85.
12. Howe HL, Chen VW, Hotes JL, Wu XC, Correa CN, Fulton JP, editors. Cancer in North America, 1994-1998. Vol 1. Incidence. Springfield (IL): North American Association of Central Cancer Registries; 2001.
13. Chen VW, Howe HL, Wu XC, Hotes JL, Correa CN, editors. Cancer in North America, 1993-1997. Vol 1. Incidence. Springfield (IL): North American Association of Central Cancer Registries; 2000.
14. Koh HK, Norton LA, Geller AC, Sun T, Rigel DS, Miller DR, et al. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. J Am Acad Dermatol 1996;34:971-8.
15. Jonna BP, Delfino RJ, Newman WG, Tope WD. Positive predictive value for presumptive diagnoses of skin cancer and compliance with follow-up among patients attending a community screening program. Prev Med 1998;27:611-6.
16. Rigel DS, Friedman RJ, Kopf AW, Weltman R, Prioleau PG, Safai B, et al. Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol 1986;14:857-60.
17. Gong G, Whittemore AS, West D, Moore DH 2nd. Cutaneous melanoma at Lawrence Livermore National Laboratory: comparison with rates in two San Francisco bay area counties. Cancer Causes Control 1992;3:191-7.
18. Philipp R, Hastings A, Briggs J, Sizer J, Are malignant melanoma time trends explained by changes in histopathological criteria for classifying pigmented skin lesions? J Epidemiol Community Health 1988;42:14-6.
19. Van Der Esch EP, Muir CS, Nectoux J, Macfarlane G, Maisonneuve P, Bharucha H, et al. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991;47:483-9.
20. Roffers SD. Demystifying total quality management in the cancer registry. Abstract 1990;17:11-6.
21. Fulton JP, Howe HL. Evaluating the incidence-mortality ratios in estimating completeness of cancer registration. In: Howe HL, editor. Cancer incidence in North America, 1988-1991. Sacramento (CA): North American Association of Central Cancer Registries; 1995: vi-1-vi-9.
22. Tucker TC, Howe HL, Weir HK. Certification of population-based cancer registries. J Regist Manage 1999;26:24-7.
23. Maudsley G, Williams EM. Variability of skin cancer registration practice in the United Kingdom. J Epidemiol Community Health 1997;51:337-8.
24. Astrom M, Bodin L, Tidefelt U. Adjustment of incidence rates after an estimate of completeness and accuracy in registration of acute leukemias in a Swedish population. Leuk Lymphoma 2001;41:559-70.
25. Black WC, Palmer C, Varsa E, Bartow SA, Foucar E, Burgdorf WH. The New Mexico Melanoma Registry: a model of a statewide cooperative program. Am J Dermatopathol 1987;9:10-4.